Introduction
An increased risk of fracture is a feature of Turner syndrome (TS). However, the reason for this is unclear, and forearm fractures have been estimated to be more prevalent in the TS population. 1 Some studies also reported an increase in fracture prevalence during childhood in these patients. 2 Exogenous recombinant human growth hormone (rhGH) is often used in childhood to increase height. The role of growth hormone (GH) treatment in promoting bone accrual has not yet been completely defined, although the administration of GH is known to increase bone mineral density (BMD) in children without TS. 3, 4 Studies using dual energy X-ray absorptiometry (DXA) demonstrate a reduction in BMD in children and adolescents with TS. [5] [6] [7] However, these studies do not take into account changes in bone size, which influence BMD in the case of short-statured patients. DXA studies, when adjusted for bone size, find no differences in volumetric BMD (vBMD) between TS girls and controls. 8 Peripheral quantitative computed tomography (pQCT) is able to provide precise measurements of 3-dimensional bone density without being influenced by bone size. In TS girls, pQCT data suggests that cortical density is reduced with sparing of trabecular bone. 9 In recent years, another promising method of assessing skeletal status was introduced. This method is based on ultrasound waves, which are transmitted through the bone tissue. Phalangeal quantitative ultrasound (phQUS) measurements have demonstrated an ability to reveal changes due to skeletal growth, aging, and bone and mineral disorders. [10] [11] [12] [13] [14] Quantitative ultrasound (QUS) is also devoid of ionizing radiation, and is cost-effective, easy to use and portable -all highly desirable features in pediatrics. There is data on girls with TS whose bone mineral status was assessed by 2 different techniques, i.e., DXA and phQUS. Despite its pitfalls, DXA is recommended as a monitoring tool in children with chronic disease who are at risk of developing osteoporosis; phQUS, however, is able to provide measurements of bone quality without being influenced by bone size. The objective of our study was to assess bone status in young girls with TS by 2 different densitometric techniques, DXA and phQUS, and to evaluate the relationship between low bone density and the prevalence of fracture. This is the first study to concurrently examine the lumbar spine (LS) BMD height-adjusted Z-score and amplitude-dependent speed of sound (Ad-SoS) Z-score in Polish TS girls.
Material and methods

Patients
In the study, 43 Caucasian Polish girls with TS aged 13.7 ±3.4 years (range 5.3-18.3) were enrolled as outpatients to the Department and Clinic of Endocrinology and Diabetology for Children and Adolescents or the Department and Clinic of Endocrinology, Diabetes and Isotope Therapy of Wroclaw Medical University, Poland. They were sent an invitation with an informational letter. After consent was given, a questionnaire detailing fracture history was completed by the participants and/or their parents or guardians. The diagnosis of TS was made by karyotyping (45,X = 22, deletion = 4 and mosaic = 17). The clinical characteristics of the study group are presented in Table 1 .
None of our patients suffered from other conditions known to be associated with disrupted mineral metabolism. Recombinant human growth hormone was administered at a dose of 0.33 mg/kg/week. In all patients diagnosed before puberty, pubertal development was induced at the age of 12 with the most physiological form of estrogen available for replacement. Starting from a daily dose of 0.25 mg, 17β-estradiol was administered orally in increasing doses. Progesterone was added after at least 1 year of estrogenization. In case of a late diagnosis of TS, rhGH was administered first, and pubertal induction began 1 year later. Twenty-three girls had been treated with estrogens and only 6 with hormone replacement therapy (HRT).
Study design
In order to assess skeletal status in all patients, we evaluated LS BMD by DXA, and Ad-SoS using QUS. Phalangeal QUS results were compared with reference data for Polish girls and the Ad-SOS Z-score was calculated. 13, 14 From the DXA results -in order to avoid misdiagnosis in the case of the assessment of short individuals -we calculated LS aBMD height-adjusted Z-score based on the Z-score calculator of the Bone Mineral Density in Childhood Study (BMDCS) for Hologic Systems, which was sponsored by the Eunice Kennedy Shriver National Institute of Childhood and Human Development (NICHD). The normative data from this project is currently considered to be the gold standard for pediatric norms. 15 The LS aBMD height-adjusted Z-score deals better with the stature issue than bone mineral apparent density (BMAD) Z-score. 16 Standing height was measured with a floor-mounted stadiometer, body weight was measured to the nearest 0.1 kg with a standard medical scale, and body mass index (BMI) was calculated [kg/m 2 ]. Height, weight, and BMI were expressed as a standard deviation score (SDS) and were calculated using references from the Polish general population.
Informed verbal consent was obtained from all girls and written consent was given by parents/guardians and the girls who were older than 18 years. The study was approved by the Ethics Committee at Wroclaw Medical University.
Assessment of bone mineral status and the prevalence of fracture
Phalangeal QUS was measured using a DBM Sonic Bone Profiler (Igea, Carpi, Modena, Italy), which measures the amplitude-dependent speed of sound [m/s] at the proximal phalanges of dominant-hand fingers. Ad-SoS [m/s] was measured in the distal metaphyses of the proximal phalanges of the 2 nd -5 th fingers of the dominant hand, taking into account the first signal with an amplitude of at least 2 mV at the receiving probe. Thus, the measured speed of sound is specified as "amplitude-dependent." All phQUS measurements were performed by the same operator (ZPH). The precision error for QUS results was previously established by 5 serial measurements and expressed as the root-mean-square coefficient of variation (RMS-%CV). RMS-%CV for Ad-SoS was 0.64%.
Lumbar spine areal bone mineral density (LS aBMD) was measured by a Discovery W densitometer (Hologic Inc., Bedford, USA) using APEX software (release 4.5.2.1, Hologic Inc.), and the LS aBMD Z-score was calculated. The coefficient of precision was about 1% for LS aBMD.
For all patients, the frequency and severity of injury and the sites of fractures were recorded and classified according to the Landin severity scale.
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Statistical analysis
From the phQUS and DXA results obtained, Z-scores were calculated as the difference between the patient's value and the age-specific mean, divided by the reference group's standard deviation (SD) [Z-score = (test result for patient − age-specific mean in reference population)/agespecific SD in reference population].
All calculations were done using R v. 3.2.4 (R Foundation for Statistical Computing, Vienna, Austria). Descriptive statistics were presented as mean values, standard deviations, and value ranges for continuous variables. Distribution normality was tested by the Shapiro-Wilk test of normality. In the case of nonparametric data, the Yeo-Johnson transformation was used to reduce skewness and to approximate normality. For a comparative analysis of normally distributed variables, the ANOVA algorithm, Student's t-test, and multiple comparisons of means by Tukey contrasts were used. For comparative analysis of non-normal distributed variables, the Fisher-Pitman permutation test was used. Depending on the distribution of the variables analyzed, Pearson's or Spearman's correlation coefficients were used to estimate the associations between 2 variables. Significance was assumed at p < 0.05.
Results
A total of 43 girls with genetically confirmed TS aged 5-18 years participated in the study. The mean height SDS was significantly below that of age-matched Polish girls, whereas the mean weight SDS did not differ significantly from that of age-matched Polish girls, and the mean BMI SDS was significantly greater (Table 1) . Of the 43 girls, 7 (16%) were prepubertal, 22 (51%) had reached Tanner stage 2 or higher pubarche or breast development without menarche, and 14 (33%) were postmenarche. Although the mean LS aBMD Z-score was significantly lower than 0 (the hypothetical mean) when compared with a reference population (p = 0.001), the mean LS aBMD height-adjusted Z-score did not differ significantly from 0 (Fig. 1) . The AdSoS Z-score was significantly lower than 0 compared to a Polish reference population (p = 0.001) (Fig. 2) . The LS aBMD height-adjusted Z-score was ≤−2 in 1 out of 43 girls (2%), and the Ad-SoS Z-score was ≤−2 in 11 out of 43 girls (26%). None of the patients reported pathological fractures. Nine girls had fractures caused by medium-force-trauma (21%), including 1 patient who reported 2 fractures. All fractures involved the appendicular skeleton, but not vertebral or femoral sites. We did not find significant differences between patients with and without fractures as regards the Ad-SoS and LS aBMD height-adjusted Z-scores. Only 1 girl, who had sustained 2 fractures, had an LS aBMD height-adjusted Z-score of <−2; the others showed normal values. The Ad-SoS Z-score was ≤−2 in 3 girls with a positive history of fracture (including the girl with 2 fractures). We did not find any differences in Ad-SoS and BMD values in relation to karyotype or age of diagnosis. The DXA and QUS parameters did not correlate with age at the start of GH therapy and cumulative doses of GH. 
Discussion
Although short stature is the most common clinical feature of TS, skeletal abnormalities encompass more than poor linear growth. One of the biggest concerns is that Ad-SoS Z-score serial number of patients of increased fracture risk and decreased bone density. Studies using DXA show decreased BMD, but small size leads to underestimation, and when the results are adjusted for body size, patients with TS usually have normal BMD in the spine, i.e., in trabecular bone. 2, 18, 19 This phenomenon also occurred in our study, showing that apparent BMD may be misleading when evaluating patients with short stature. Although the majority of studies indicate that the abnormalities seem to be only in cortical bone, some studies show compromised trabecular microarchitecture in patients with TS. 20, 21 However, reduced cortical BMD in young TS patients is not proven to lead to increased fractures. [22] [23] [24] We assessed the skeletal status of a group of young females with TS at 2 different skeletal sites using 2 different densitometric techniques. Phalangeal QUS measurements have shown an ability to reveal changes due to skeletal disorders and seem to be less influenced by bone size. [10] [11] [12] Furthermore, as proximal phalanges of the hands consist primarily of cortical bone (>60%), a phalangeal QUS evaluation may provide more information on bone health in TS girls than DXA. Our patients had statistically significantly lower Ad-SoS values compared to healthy Polish girls, but not LS BMD values after adjusting for height. These findings are in agreement with other studies demonstrating that in young TS girls, at a site with predominantly trabecular bone (i.e., the lumbar spine), BMD does not differ from controls after adjusting for body size. 2, 9, 18, 19, 25 However, reduced BMD may be present at sites of predominantly cortical bone, such as the 1/3 distal radius. 23 Also, the studies that used pQCT, a method which is able to independently provide measurements of 3-dimensional bone density and an assessment of trabecular and cortical bone density, have revealed significantly reduced cortical volumetric BMD (vBMD) and cortical thickness at some sites, and lower bone strength. [20] [21] [22] Holroyd et al. showed by this method not only a significant reduction in cortical vBMD at the proximal radius, but in cortical thickness as well (Z-score of −2.58 and −2.89, respectively). 9 Moreover, they found no differences in the total vBMD Z-score or the trabecular vBMD Z-score at the distal radius. Using ultrasound methods, comparable results were obtained by Zuckerman-Levin et al. and Vierucci et al. 24, 26 As in our study, they found reduced phalangeal Ad-SoS, and radial and tibial SoS in girls and women with TS. As with pQCT data, abnormal QUS results may imply structural abnormalities in cortical bone in TS. In contrast, Soucek et al. questioned the findings that the cortical BMD is decreased in TS. They concluded that the partial volume effect is probably responsible for this outcome. 27 The fracture prevalence in our patients was 21%, and was similar to other observations. 28, 29 This percentage is not higher than in a healthy population, because fractures are also common in youth, with 1/3 of all children sustaining at least 1 fracture before the age of 17 years. 30, 31 Our finding varies from a paper by Vierucci et al. 26 They found a slightly increased risk of fracture in TS girls. In the study, 62.5% of their TS patients had an Ad-SoS Z-score of <−2 and only 1 TS patient with positive history of fracture had normal QUS values, whereas 67% of our TS girls with a previous history of fracture had an Ad-SoS Z-score of >−2. We also did not find any differences in Ad-SoS values between TS girls with and without a positive history of fracture. Unfortunately, we did not assess bone transmission time (BTT), which was shown by Vierucci et al. to have a strong correlation with previous fractures. These differences are difficult to explain. Perhaps this conflicting data resulted from the earlier age of our patients at the start of rhGH therapy, but we found no correlation between QUS values and the onset of GH treatment. Also, the relatively small number of subjects included in these studies may be behind the dissimilarities encountered. Unlike Vierucci et al., we examined the dominant hand, because the Polish reference values were calculated on the basis of dominant hand measurements, 14 but studies by Shönau et al. and Baroncelli et al. have showen that there is no significant difference between measurements of the two hands. 32, 33 Although GH administration, the standard treatment for TS patients, is considered to promote bone accrual and strength, we found no correlation between the cumulative dose of GH and densitometric results. 21 Similar results have been obtained by other authors. 5, 34, 35 Furthermore, karyotype did not influence densitometric Z-score values, which was also in an agreement with previous studies. 34, 36 Our study may have been limited by its cross-sectional design and the small number of subjects studied. However, the rarity of TS limits the potential for enrollment. Indeed, other studies assessing skeletal status in young TS patients encompass a similar number of subjects. A longitudinal study in patients with TS is in progress, and the results of this study may furnish further important data.
